Published Date: 10 Mar 2023
United States: The US research team recommended using a different agent to enhance the Doppler profile for more accurate measurements.
Read Full NewsListener feedback, more long-term data on the TAVR/SAVR question, population prevalence of valvular heart disease in the US, and a CMS proposal to expand TAVR coverage are the topics John Mandrola, MD, discusses in this week’s podcast.
False claims about poultry vaccination continue to circulate despite evidence supporting its role in protecting livestock and limiting the spread of avian influenza.
Severe esophageal symptoms that do not respond to standard treatment may warrant endoscopic evaluation and targeted diagnostic testing.
10-hour time-restricted eating promotes greater weight loss and improved body composition in adults with obesity and without diabetes than standard dietary counseling alone.
Panelists at HLTH Europe 2026 warned that clinicians and patients are increasingly deferring to algorithmic outputs over independent judgment.
In patients with systemic sclerosis, specific gastrointestinal manifestations are linked to distinct cardiac complications, a recent study shows.
1.
Talquetamab Combos Show Survival Benefit in r/r Myeloma
2.
Year in Review: Chronic Lymphocytic Leukemia
3.
What Kate Middleton Reminds Us About the Role of Privacy in Healing.
4.
New clinical recommendation for local treatment of oligometastatic lung cancer.
5.
Early Results for Anorexia Nervosa with Psilocybin.
1.
Tumor Evolution Forecasting for Precision Oncology Decisions
2.
Anemia Symptoms: What You Need to Know
3.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
4.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
5.
The Algorithmic Oncologist: A Comparative Clinical Review of AI in Predictive Cancer Planning
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
2.
Updates on the First Line Management of ALK+ NSCLC
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation